Delivery of Recombinant Adeno-Associated Virus-Mediated Human Tissue Kallikrein for Therapy of Chronic Renal Failure in Rats

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Gene Therapy

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.2007.138PMID 18402547PMCID PMC2376255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The kallikrein-kinin system in health and in diseases of the kidney.

  2009cited by this paper
• Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis

  2009cited by this paper
• Kallikreins: unravelling the genetics of autoimmune glomerulonephritis.

  2009cited by this paper
• Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.

  2007cited by this paper
• Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis.

  2006cited by this paper
• Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.

  2006cited by this paper
• Binding and Signal Transduction Characteristics of the Nonpeptide Vasopressin V1A Receptor-Selective Antagonist YM218 in Cultured Rat Mesangial Cells

  2006cited by this paper
• Role of endothelin and endothelin receptor antagonists in renal disease

  2006cited by this paper
• Projecting the number of patients with end-stage renal disease in the United States to the year 2015.

  2005cited by this paper
• Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.

  2004cited by this paper
• Prophylaxis of Iodinated Contrast Media-Induced Nephropathy: A Pharmacological Point of View

  2004cited by this paper
• Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection.

  2004cited by this paper
• Stimulation of Cyclic GMP Production via AT2 and B2 Receptors in the Pressure-Overloaded Aorta After Banding

  2004cited by this paper
• Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries

  2004influential reference
• Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1.

  2002cited by this paper
• Effect of Mycophenolate Mofetil on Kallikrein Expression in the Kidney of 5/6 Nephrectomized Rats

  2002cited by this paper
• Protein Tyrosine Phosphatases Are Up-regulated and Participate in Cell Death Induced by Polyglutamine Expansion*

  2002cited by this paper
• ESRD patients in 2001: global overview of patients, treatment modalities and development trends.

  2002cited by this paper
• Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion

  2002cited by this paper
• Association of the tissue kallikrein gene promoter with ESRD and hypertension.

  2002cited by this paper
• Isolation of Highly Infectious and Pure Adeno-Associated Virus Type 2 Vectors with a Single-Step Gravity-Flow Column

  2001cited by this paper
• Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor.

  2001cited by this paper
• Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats

  2001cited by this paper
• Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.

  2001cited by this paper
• Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.

  2000cited by this paper
• Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

  2000cited by this paper
• Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.

  2000cited by this paper
• Enhanced renal function in bradykinin B(2) receptor transgenic mice.

  2000cited by this paper
• Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

  1999cited by this paper
• Localization and Expression of Tissue Kallikrein and Kallistatin in Human Blood Vessels

  1999cited by this paper
• Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.

  1998cited by this paper
• Renal Hypersensitivity to Vasopressin in Congestive Heart Failure

  1998cited by this paper
• Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia

  1998cited by this paper
• Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive Rats

  1998cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Renal dopamine receptors in health and hypertension.

  1998cited by this paper
• Bradykinin receptors.

  1997cited by this paper
• Role of endothelin in hypertension of experimental chronic renal failure.

  1997cited by this paper
• Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland.

  1996cited by this paper
• The role of renal natriuretic depressor systems on hypertensive mechanisms in reduced renal mass hypertensive rats.

  1995cited by this paper
• Physiologic and pathophysiologic roles of endothelin in the kidney.

  1994cited by this paper
• Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II.

  1994cited by this paper
• Human tissue kallikrein induces hypotension in transgenic mice.

  1994cited by this paper
• Evidence that intrarenal bradykinin plays a role in regulation of renal function.

  1993cited by this paper
• Whole body autoregulation in reduced renal mass hypertension.

  1992cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats.

  1991cited by this paper
• The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation.

  1989cited by this paper
• Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases.

  1989cited by this paper
• Renal kallikrein-kinin system.

  1986cited by this paper
• Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

  1984cited by this paper
• The renal kallikrein-kinin system.

  1979cited by this paper
• Stability of Blood Pressure Rank and Urinary Kallikrein Concentration in Childhood: An Eight-Year Follow-Up

  1978cited by this paper
• Urinary Kallikrein Excretion in Hypertensive Man: Relationships to Sodium intake and Sodium‐Retaining Steroids

  1974cited by this paper
• Altered Urinary Kallikrein Excretion in Rats with Hypertension

  1972cited by this paper

• hKLK alleviates myocardial fibrosis in mice with viral myocarditis.

  2023cites this paper
• Kinin receptors regulate skeletal muscle regeneration: differential effects for B1 and B2 receptors

  2023cites this paper
• Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

  2020cites this paper
• The kallikrein–kinin system in diabetic kidney disease

  2017cites this paper
• Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors

  2017cites this paper
• Preserved Erectile Function in the Aged Transgenic Rat Harboring Human Tissue Kallikrein 1.

  2016cites this paper
• Up-regulation of the kinin B2 receptor pathway modulates the TGF-β/Smad signaling cascade to reduce renal fibrosis induced by albumin.

  2015cites this paper
• Repair effect of coexpression of the hVEGF and hBMP genes via an adeno-associated virus vector in a rabbit model of early steroid-induced avascular necrosis of the femoral head.

  2015cites this paper
• Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors

  2015cites this paper
• Pre-stimulation of the kallikrein system in cisplatin-induced acute renal injury: an approach to renoprotection.

  2014cites this paper
• Targeted gene delivery via N-acetylglucosamine receptor mediated endocytosis.

  2014cites this paper
• Relation of Plasma Tissue Kallikrein Levels to Presence and Severity of Coronary Artery Disease in a Chinese Population

  2014cites this paper
• N-Acetylglucosamine-conjugated block copolymer consisting of poly(ethylene oxide) and cationic polyaspartamide as a gene carrier for targeting vimentin-expressing cells.

  2014cites this paper
• Bradykinin Inhibits Oxidative Stress-Induced Cardiomyocytes Senescence via Regulating Redox State

  2013cites this paper
• Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.

  2013cites this paper
• Association of Functional Kallikrein-1 Promoter Polymorphisms and Acute Kidney Injury: A Case-Control and Longitudinal Cohort Study

  2013cites this paper
• CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice[S]

  2013cites this paper
• CALL FOR PAPERS Integrative Aspects of Renal Endocrinology Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy

  2012cites this paper
• Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis

  2012influential citation
• Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: A multicenter case–control study in China

  2011cites this paper
• Telmisartan protects against insulin resistance by attenuating inflammatory response in rats

  2011cites this paper
• Proteases as therapeutics.

  2011cites this paper
• Telmisartan protects against insulin resistance by attenuating inflammatory response in rats

  2011cites this paper
• Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats

  2010cites this paper
• Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats

  2010cites this paper
• Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo

  2010cites this paper
• Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice

  2010cites this paper
• The kallikrein-kinin system in health and in diseases of the kidney.

  2009cites this paper
• Kallikreins: unravelling the genetics of autoimmune glomerulonephritis.

  2009cites this paper
• Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis

  2009cites this paper